Share-Based Compensation (Tables)

9 Months Ended

Oct. 27, 2012

Assumptions used to Compute Share-Based Compensation Expense

The following table shows the Company’s assumptions used to compute the share-based compensation expense:

	Stock Option Plans Thirty-nine weeks ended						Stock Purchase Plan Thirty-nine weeks ended
	October 27,			October 29,			October 27,			October 29,
	2012			2011			2012			2011
Weighted-average risk free rate of interest		1.5	%		2.07	%		0.22	%		0.34	%
Expected volatility		43	%		45	%		38	%		37	%
Weighted-average expected award life		5.5 years			5.0 years			1.0 year			1.0 year
Dividend yield		2.3	%		3.5	%		2.5	%		3.5	%
Weighted-average fair value	$	10.12		$	5.86		$	5.91		$	3.69

Options Granted under Stock Option Plans

The information in the following table covers options granted under the Company’s stock option plans for the thirty-nine weeks ended October 27, 2012:

(in thousands, except weighted-average term and price per share)	Shares			Weighted- Average Term		Weighted- Average Exercise Price
Options outstanding at the beginning of the year		7,227				$	18.44
Granted		932				$	30.93
Exercised		(1,827	)			$	19.45
Expired or cancelled		(40	)			$	23.68
Options outstanding at October 27, 2012		6,292			6.29	$	19.96
Options exercisable at October 27, 2012		3,977			4.93	$	18.11
Options available for future grant at October 27, 2012		5,558

Aggregate Intrinsic Value for Stock Options Outstanding and Exercisable

	Thirteen weeks ended				Thirty-nine weeks ended
	October 27,		October 29,		October 27,		October 29,
Intrinsic value of stock options (in millions)	2012		2011		2012		2011
Exercised	$	9	$	—	$	24	$	8
Outstanding					$	85	$	42
Outstanding and exercisable					$	61	$	27

Stock Options Outstanding and Exercisable

The following table summarizes information about stock options outstanding and exercisable at October 27, 2012:

				Options Outstanding						Options Exercisable
Range of Exercise Prices				Number Outstanding		Weighted- Average Remaining Contractual Life		Weighted- Average Exercise Price		Number Exercisable		Weighted- Average Exercise Price
(in thousands, except price per share and contractual life)
$	9.85	$	15.10		2,283		6.34	$	12.52		1,888	$	11.98
$	15.74	$	23.92		2,202		6.58	$	20.45		1,250	$	21.65
$	24.04	$	34.12		1,807		5.88	$	28.76		839	$	26.62
$	9.85	$	34.12		6,292		6.29	$	19.96		3,977	$	18.11

Changes in Nonvested Options

Changes in the Company’s nonvested options for the thirty-nine weeks ended October 27, 2012 are summarized as follows:

(in thousands, except price per share)	Number of Shares			Weighted- Average Grant Date Fair Value per Share
Nonvested at January 28, 2012		2,629		$	16.84
Granted		932		$	30.93
Vested		(1,206	)	$	15.43
Expired or cancelled		(40	)	$	23.68
Nonvested at October 27, 2012		2,315		$	23.13

Restricted Shares and Units Activity

Restricted shares and units activity for the thirty-nine weeks ended October 27, 2012 and October 29, 2011 is summarized as follows:

	Number of Shares and Units
(in thousands)	October 27, 2012			October 29, 2011
Outstanding at beginning of period		2,068			1,759
Granted		264			686
Vested		(482	)		(327	)
Cancelled or forfeited		—			(50	)
Outstanding at end of period		1,850			2,068
Aggregate value (in millions)	$	33		$	30
Weighted-average remaining contractual life		0.95 years			1.44 years